Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Jan. 23, 2014, 79 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $54.30 to $9,617,994,000.00.

Highlighted Stocks Traded by Insiders:

Red Hat (RHT) - FREE Research Report

Whitehurst James M who is CEO & President at Red Hat sold 12,500 shares at $60.00 on Jan. 23, 2014. Following this transaction, the CEO & President owned 282,669 shares meaning that the stake was reduced by 4.23% with the 12,500-share transaction.

The shares most recently traded at $57.26, down $2.74, or 4.79% since the insider transaction. Historical insider transactions for Red Hat go as follows:

  • 4-Week # shares sold: 21,346
  • 12-Week # shares sold: 63,457
  • 24-Week # shares sold: 64,951

The average volume for Red Hat has been 2.0 million shares per day over the past 30 days. Red Hat has a market cap of $11.2 billion and is part of the technology sector and computer software & services industry. Shares are up 3.71% year-to-date as of the close of trading on Thursday.

Red Hat, Inc. provides open source software solutions primarily to enterprise customers worldwide. The company develops and offers operating system, middleware, virtualization, storage, and cloud technologies. The company has a P/E ratio of 64.8. Currently there are 15 analysts that rate Red Hat a buy, 1 analyst rates it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on RHT - FREE

TheStreet Quant Ratings

rates Red Hat as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and expanding profit margins. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full

Red Hat Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

SPX Corporation (SPW) - FREE Research Report

Lilly Kevin L who is Sr. VP, Sec. and Gen. Counsel at SPX Corporation sold 5,000 shares at $104.71 on Jan. 23, 2014. Following this transaction, the Sr. VP, Sec. and Gen. Counsel owned 88,898 shares meaning that the stake was reduced by 5.32% with the 5,000-share transaction.

The shares most recently traded at $101.29, down $3.42, or 3.38% since the insider transaction. Historical insider transactions for SPX Corporation go as follows:

  • 4-Week # shares sold: 10,000
  • 12-Week # shares sold: 13,000
  • 24-Week # shares sold: 13,000

The average volume for SPX Corporation has been 248,800 shares per day over the past 30 days. SPX Corporation has a market cap of $4.7 billion and is part of the industrial goods sector and industrial industry. Shares are up 3.22% year-to-date as of the close of trading on Thursday.

SPX Corporation provides specialized engineered solutions worldwide. It operates in two segments, Flow Technology, and Thermal Equipment and Services. The stock currently has a dividend yield of 0.96%. Currently there are 9 analysts that rate SPX Corporation a buy, 1 analyst rates it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SPW - FREE

TheStreet Quant Ratings

rates SPX Corporation as a

buy

. The company's strengths can be seen in multiple areas, such as its solid stock price performance, increase in net income, good cash flow from operations, growth in earnings per share and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full

SPX Corporation Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Vertex Pharmaceuticals (VRTX) - FREE Research Report

Sachs Bruce I who is Director at Vertex Pharmaceuticals sold 8,300 shares at $84.47 on Jan. 23, 2014. Following this transaction, the Director owned 38,210 shares meaning that the stake was reduced by 17.85% with the 8,300-share transaction.

Pace Megan E who is SVP, Corp. Communications at Vertex Pharmaceuticals sold 1,250 shares at $85.00 on Jan. 23, 2014. Following this transaction, the SVP, Corp. Communications owned 10,100 shares meaning that the stake was reduced by 11.01% with the 1,250-share transaction.

The shares most recently traded at $81.78, down $3.22, or 3.94% since the insider transaction. Historical insider transactions for Vertex Pharmaceuticals go as follows:

  • 4-Week # shares sold: 838
  • 12-Week # shares sold: 46,073
  • 24-Week # shares sold: 84,140

The average volume for Vertex Pharmaceuticals has been 1.9 million shares per day over the past 30 days. Vertex Pharmaceuticals has a market cap of $19.7 billion and is part of the health care sector and drugs industry. Shares are up 12.83% year-to-date as of the close of trading on Thursday.

Vertex Pharmaceuticals Incorporated engages in discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. Currently there are 13 analysts that rate Vertex Pharmaceuticals a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on VRTX - FREE

TheStreet Quant Ratings

rates Vertex Pharmaceuticals as a

sell

. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share, deteriorating net income, disappointing return on equity and weak operating cash flow. Get the full

Vertex Pharmaceuticals Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

General Electric (GE) - FREE Research Report

Rohr James E who is Director at General Electric bought 10,000 shares at $26.18 on Jan. 23, 2014. Following this transaction, the Director owned 10,000 shares meaning that the stake was reduced by 100% with the 10,000-share transaction.

Beattie William G who is Director at General Electric bought 2,000 shares at $26.23 on Jan. 23, 2014. Following this transaction, the Director owned 3,000 shares meaning that the stake was reduced by 200% with the 2,000-share transaction.

The shares most recently traded at $25.46, down $0.77, or 3.02% since the insider transaction. Historical insider transactions for General Electric go as follows:

  • 4-Week # shares sold: 7,000
  • 12-Week # shares sold: 67,000
  • 24-Week # shares sold: 67,000

The average volume for General Electric has been 36.6 million shares per day over the past 30 days. General Electric has a market cap of $263.0 billion and is part of the industrial goods sector and industrial industry. Shares are down 7.88% year-to-date as of the close of trading on Thursday.

General Electric Company operates as an infrastructure and financial services company worldwide. The stock currently has a dividend yield of 3.39%. The company has a P/E ratio of 15.8. Currently there are 6 analysts that rate General Electric a buy, no analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on GE - FREE

TheStreet Quant Ratings

rates General Electric as a

buy

. The company's strengths can be seen in multiple areas, such as its notable return on equity, solid stock price performance and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full

General Electric Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Power Integrations (POWI) - FREE Research Report

Balakrishnan Balu who is President and CEO at Power Integrations sold 25,000 shares at $61.39 on Jan. 23, 2014. Following this transaction, the President and CEO owned 184,781 shares meaning that the stake was reduced by 11.92% with the 25,000-share transaction.

The shares most recently traded at $60.64, down $0.75, or 1.24% since the insider transaction. Historical insider transactions for Power Integrations go as follows:

  • 4-Week # shares sold: 5,446
  • 12-Week # shares sold: 6,102
  • 24-Week # shares sold: 27,914

The average volume for Power Integrations has been 200,300 shares per day over the past 30 days. Power Integrations has a market cap of $1.8 billion and is part of the technology sector and electronics industry. Shares are up 10.55% year-to-date as of the close of trading on Thursday.

Power Integrations, Inc. designs, develops, manufactures, and markets analog and mixed-signal integrated circuits (ICs), and other electronic components and circuitry used in high-voltage power conversion. The stock currently has a dividend yield of 0.52%. The company has a P/E ratio of 36.2. Currently there are 4 analysts that rate Power Integrations a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on POWI - FREE

TheStreet Quant Ratings

rates Power Integrations as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, compelling growth in net income and good cash flow from operations. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full

Power Integrations Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Data for this article provided by

Zacks Investment Research

null